Medtecs International Corporation Limited (SGX:546)
Singapore
· Delayed Price · Currency is SGD 0.113
-0.001 (-0.88%)
At close: Mar 9, 2026
SGXC:546 Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 78.95 | 54.42 | 52.64 | 56.24 | 144.16 | Upgrade
|
| Revenue Growth (YoY) | 45.06% | 3.39% | -6.41% | -60.98% | -63.99% | Upgrade
|
| Cost of Revenue | 66.53 | 47.54 | 46.68 | 59.58 | 100.68 | Upgrade
|
| Gross Profit | 12.42 | 6.88 | 5.96 | -3.34 | 43.48 | Upgrade
|
| Selling, General & Admin | 16.83 | 23.28 | 24.94 | 29.73 | 27.47 | Upgrade
|
| Other Operating Expenses | -1.4 | - | - | - | - | Upgrade
|
| Operating Expenses | 17.71 | 35.36 | 30.95 | 29.73 | 27.47 | Upgrade
|
| Operating Income | -5.29 | -28.47 | -24.99 | -33.07 | 16.01 | Upgrade
|
| Interest Expense | -0.81 | -0.76 | -0.74 | -0.82 | -0.85 | Upgrade
|
| Interest & Investment Income | 0.92 | 1.46 | 1.43 | 0.91 | 0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.63 | -0.04 | 0.83 | 0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 1.08 | 1.27 | 1.21 | 1.64 | Upgrade
|
| EBT Excluding Unusual Items | -5.19 | -26.07 | -23.07 | -30.94 | 16.86 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 2.23 | 0.35 | 0.17 | 0.06 | Upgrade
|
| Other Unusual Items | - | 0.39 | 0.21 | 0.04 | - | Upgrade
|
| Pretax Income | -5.19 | -23.44 | -22.52 | -30.65 | 16.92 | Upgrade
|
| Income Tax Expense | -0.36 | 0.51 | -0.03 | -1.39 | 0.41 | Upgrade
|
| Earnings From Continuing Operations | -4.83 | -23.95 | -22.49 | -29.26 | 16.51 | Upgrade
|
| Minority Interest in Earnings | -0.01 | 1.53 | 1.42 | 0.67 | 0.83 | Upgrade
|
| Net Income | -4.84 | -22.42 | -21.07 | -28.6 | 17.34 | Upgrade
|
| Net Income to Common | -4.84 | -22.42 | -21.07 | -28.6 | 17.34 | Upgrade
|
| Net Income Growth | - | - | - | - | -86.83% | Upgrade
|
| Shares Outstanding (Basic) | 545 | 545 | 545 | 545 | 547 | Upgrade
|
| Shares Outstanding (Diluted) | 545 | 545 | 545 | 545 | 547 | Upgrade
|
| Shares Change (YoY) | - | - | -0.07% | -0.30% | -0.46% | Upgrade
|
| EPS (Basic) | -0.01 | -0.04 | -0.04 | -0.05 | 0.03 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.04 | -0.04 | -0.05 | 0.03 | Upgrade
|
| EPS Growth | - | - | - | - | -86.77% | Upgrade
|
| Free Cash Flow | -6.1 | -0.98 | -12.08 | -16.26 | 13.73 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.00 | -0.02 | -0.03 | 0.03 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.006 | Upgrade
|
| Dividend Growth | - | - | - | - | -88.07% | Upgrade
|
| Gross Margin | 15.73% | 12.65% | 11.32% | -5.93% | 30.16% | Upgrade
|
| Operating Margin | -6.70% | -52.32% | -47.47% | -58.80% | 11.11% | Upgrade
|
| Profit Margin | -6.13% | -41.20% | -40.02% | -50.84% | 12.03% | Upgrade
|
| Free Cash Flow Margin | -7.72% | -1.80% | -22.94% | -28.91% | 9.52% | Upgrade
|
| EBITDA | -1.78 | -24.09 | -20.76 | -29.78 | 19.69 | Upgrade
|
| EBITDA Margin | -2.26% | -44.26% | -39.44% | -52.95% | 13.66% | Upgrade
|
| D&A For EBITDA | 3.51 | 4.39 | 4.23 | 3.29 | 3.68 | Upgrade
|
| EBIT | -5.29 | -28.47 | -24.99 | -33.07 | 16.01 | Upgrade
|
| EBIT Margin | -6.70% | -52.32% | -47.47% | -58.80% | 11.11% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 2.41% | Upgrade
|
| Advertising Expenses | - | - | - | - | 1.44 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.